SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-007223
Filing Date
2022-05-05
Accepted
2022-05-05 07:09:44
Documents
82
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bcyc-20220331x10q.htm   iXBRL 10-Q 2056591
2 EX-31.1 bcyc-20220331xex31d1.htm EX-31.1 14088
3 EX-31.2 bcyc-20220331xex31d2.htm EX-31.2 14294
4 EX-32.1 bcyc-20220331xex32d1.htm EX-32.1 10815
  Complete submission text file 0001558370-22-007223.txt   8234181

Data Files

Seq Description Document Type Size
5 EX-101.SCH bcyc-20220331.xsd EX-101.SCH 74737
6 EX-101.CAL bcyc-20220331_cal.xml EX-101.CAL 52247
7 EX-101.DEF bcyc-20220331_def.xml EX-101.DEF 286847
8 EX-101.LAB bcyc-20220331_lab.xml EX-101.LAB 552122
9 EX-101.PRE bcyc-20220331_pre.xml EX-101.PRE 441307
76 EXTRACTED XBRL INSTANCE DOCUMENT bcyc-20220331x10q_htm.xml XML 1228918
Mailing Address B900 BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address B900 BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 011441223261503
BICYCLE THERAPEUTICS plc (Filer) CIK: 0001761612 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-38916 | Film No.: 22894011
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences